Advertisement
NVST vs STAA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVST is a StrongBuy and STAA is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
NVST’s FA Score shows that 1 FA rating(s) are green whileSTAA’s FA Score has 0 green FA rating(s).
- NVST’s FA Score: 1 green, 4 red.
- STAA’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NVST’s TA Score shows that 4 TA indicator(s) are bullish while STAA’s TA Score has 5 bullish TA indicator(s).
- NVST’s TA Score: 4 bullish, 4 bearish.
- STAA’s TA Score: 5 bullish, 3 bearish.
Price Growth
NVST (@Pharmaceuticals: Other) experienced а +10.77% price change this week, while STAA (@Pharmaceuticals: Other) price change was -1.59% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.56%. For the same industry, the average monthly price growth was +5.36%, and the average quarterly price growth was +5.88%.
Reported Earning Dates
NVST is expected to report earnings on Feb 11, 2026.
STAA is expected to report earnings on Feb 25, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+3.56% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| NVST | STAA | NVST / STAA | |
| Capitalization | 3.45B | 1.29B | 269% |
| EBITDA | 341M | -73.24M | -466% |
| Gain YTD | 8.813 | 7.163 | 123% |
| P/E Ratio | 233.22 | 49.73 | 469% |
| Revenue | 2.62B | 224M | 1,171% |
| Total Cash | 1.13B | 190M | 597% |
| Total Debt | 1.6B | 40.5M | 3,956% |
NVST | STAA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 17 | 5 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 86 | 93 | |
PRICE GROWTH RATING 1..100 | 52 | 50 | |
P/E GROWTH RATING 1..100 | 4 | 85 | |
SEASONALITY SCORE 1..100 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NVST's Valuation (85) in the null industry is in the same range as STAA (86) in the Medical Specialties industry. This means that NVST’s stock grew similarly to STAA’s over the last 12 months.
NVST's Profit vs Risk Rating (100) in the null industry is in the same range as STAA (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to STAA’s over the last 12 months.
NVST's SMR Rating (86) in the null industry is in the same range as STAA (93) in the Medical Specialties industry. This means that NVST’s stock grew similarly to STAA’s over the last 12 months.
STAA's Price Growth Rating (50) in the Medical Specialties industry is in the same range as NVST (52) in the null industry. This means that STAA’s stock grew similarly to NVST’s over the last 12 months.
NVST's P/E Growth Rating (4) in the null industry is significantly better than the same rating for STAA (85) in the Medical Specialties industry. This means that NVST’s stock grew significantly faster than STAA’s over the last 12 months.
| NVST | STAA | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 1 day ago 77% | 1 day ago 73% |
| Momentum ODDS (%) | 1 day ago 65% | 1 day ago 76% |
| MACD ODDS (%) | 1 day ago 57% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 64% | 1 day ago 83% |
| TrendMonth ODDS (%) | 1 day ago 66% | 1 day ago 85% |
| Advances ODDS (%) | 3 days ago 63% | 7 days ago 73% |
| Declines ODDS (%) | 11 days ago 70% | 1 day ago 85% |
| BollingerBands ODDS (%) | 1 day ago 82% | N/A |
| Aroon ODDS (%) | 4 days ago 72% | 1 day ago 69% |
Advertisement
STAA and
Correlation & Price change
A.I.dvisor indicates that over the last year, STAA has been loosely correlated with OFIX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if STAA jumps, then OFIX could also see price increases.
| Ticker / NAME | Correlation To STAA | 1D Price Change % | ||
|---|---|---|---|---|
| STAA | 100% | -0.69% | ||
| OFIX - STAA | 38% Loosely correlated | +0.06% | ||
| CSTL - STAA | 38% Loosely correlated | +0.13% | ||
| IQV - STAA | 37% Loosely correlated | -0.05% | ||
| MTD - STAA | 37% Loosely correlated | -1.29% | ||
| FLGT - STAA | 36% Loosely correlated | -2.25% | ||
More | ||||